Carrie Turich Taylor Named a VIP of the Year for Excellence in Drug Development
Carrie Taylor has managed Royal Clinical Consulting for eight years, designing protocols and creating drug development plans to gain drugs FDA approval

RALEIGH, NC, October 14, 2011 /24-7PressRelease/ -- Carrie T. Taylor, President and Chief Executive Officer for Royal Clinical Consulting, Inc., has been recognized by Cambridge Who's Who for showing dedication, leadership and excellence in drug development and consulting.

In pursuit of a Ph.D. at Walden University, Ms. Taylor became involved in her current line of work after participating in Duke University School of Medicine's biometry clinical research design program; she graduated from this university with a Master of Health Science in biometry and clinical research design.

Her professional experience totals 17 years, but she has spent the last eight years with the clinical research consulting firm, Royal Clinical Consulting, Inc. Ms. Taylor brings an expertise in oncology and early drug development phase 1 and 2 development to her role as the company's CEO. She consults for large pharmaceutical companies, and designs protocols and creates drug development plans that will gain drugs FDA approval.

Taylor is affiliated with the Drug Information Association, the Association of Clinical Research Professionals, and American Society of Public Administration. She intends to earn a Ph.D. in the near future and continue working in a more clinical and scientific role in clinical research and drug development.

For more information about Royal Clinical Consulting, Inc., visit http://www.royalclinical.com

Press Release Contact Information:

Ellen Campbell
Cambridge Who's Who
Public Relations
498 RXR Plaza, West Tower
Uniondale, NY
USA 11556
Voice: 516-535-1515 x4266
Website: Visit Our Website